Digital behaviour change and type 2 diabetes remission
Research type
Research Study
Full title
The ‘DR-EAM’ study – (Type 2) Diabetes weight Reduction - Evaluation of App coaching Model
IRAS ID
269780
Contact name
Jimmy Bell
Contact email
Sponsor organisation
The University of Westminster
ISRCTN Number
ISRCTN71342421
Clinicaltrials.gov Identifier
Duration of Study in the UK
2 years, 6 months, 26 days
Research summary
The number of people living with type 2 diabetes in the UK and globally is growing rapidly. The majority of patients will require medications to manage their diabetes. In addition, many people with type 2 diabetes also have other health problems such as high blood pressure, pain or depression. Often these conditions are treated with further medications. This can be both challenging for patients to manage and the cost of managing these conditions are high.
Recently an intensive dietary intervention (the DiRECT study) showed that weight loss delivered with intensive one-to-one support can help people with type 2 diabetes come off their medications for blood pressure and type 2 diabetes, and normalise their blood sugars. Similar results have been seen in other studies, and improvements have also been seen in cholesterol levels, pain or even depression medications, bringing positives to patients and the NHS.
Unfortunately, these face-to-face services can be expensive to deliver. Oviva™ offer a programme called Diabetes-800 which is delivered remotely, with individualised care provided by a registered dietitian. Not only is this lower cost, it also offers more flexibility to the individual patient, as face-to-face contact can be arranged at anytime from anywhere.
This project is an evaluation of the existing Diabetes-800 programme considering key clinical outcomes including weight loss, blood sugar control and medication use in 250 patients with type 2 diabetes. We will also assess quality of life, and use questionnaires to ask people their opinions of the approach.
The information received from the evaluation will quantify how much money Diabetes- 800 could save the NHS if it were rolled out at scale. We hope to provide patients with type 2 diabetes more options to manage and improve their health, reducing the risk of diabetes-related complications and minimise their medication burden.REC name
Yorkshire & The Humber - Bradford Leeds Research Ethics Committee
REC reference
20/YH/0296
Date of REC Opinion
3 Dec 2020
REC opinion
Further Information Favourable Opinion